Release issued 17th November 2004

Sulidin® 1% Nimesulide LPS® (Lamellar Promoting System®) gel for topical use has received European Patent Number 1105114 and US Patent Number 6,818,671, covering this unique non-alcoholic soluble gel formulation with a high penetration rate. Recent and ongoing clinical studies have shown the beneficial effects of this special patented topical Non-Steroidal Anti-Inflammatory (NSAID) formulation and we are looking for partners to market this product in the EU and USA.

(7th November 2004) New Clinical Study results on SULIDIN® 1% Nimesulide LPS gel presented at the 8'th World Congress on Clinical Pharamacology and Therapeutics, Brisbane, Australia, 1-6 August 2004.

(29th December 2003) Two papers on Neo-Penotran® Forte and Neo-Penotran® Forte-L have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004

(6th June 2003) Australian Patent Approval announced for SULIDIN LPS (Topical Nimesulide Gel) formulation.

(10th October 2002) Recent Patent Approvals for SULIDIN® LPS® (Topical Nimesulide Gel)

(9th October 2002) Two New Clinical study reports released for Kortos® HC Cream used in the treatment of benign anorectal diseases.